<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1117" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1117/" /><meta name="ncbi_pagename" content="CHARGE Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>CHARGE Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="CHARGE Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2012/02/02" /><meta name="citation_author" content="Seema R Lalani" /><meta name="citation_author" content="Margaret A Hefner" /><meta name="citation_author" content="John W Belmont" /><meta name="citation_author" content="Sandra LH Davenport" /><meta name="citation_pmid" content="20301296" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1117/" /><meta name="citation_keywords" content="Chromodomain-helicase-DNA-binding protein 7" /><meta name="citation_keywords" content="CHD7" /><meta name="citation_keywords" content="CHARGE Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="CHARGE Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Seema R Lalani" /><meta name="DC.Contributor" content="Margaret A Hefner" /><meta name="DC.Contributor" content="John W Belmont" /><meta name="DC.Contributor" content="Sandra LH Davenport" /><meta name="DC.Date" content="2012/02/02" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1117/" /><meta name="description" content="CHARGE is a mnemonic for coloboma, heart defects, choanal atresia, retarded growth and development, genital abnormalities, and ear anomalies. CHARGE syndrome is characterized by the following:" /><meta name="og:title" content="CHARGE Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="CHARGE is a mnemonic for coloboma, heart defects, choanal atresia, retarded growth and development, genital abnormalities, and ear anomalies. CHARGE syndrome is characterized by the following:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1117/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/charge/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1117/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CB221E040C4D10000000004B901B9.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1117_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1117_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cebpa-aml/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/chchd10-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1117_"><span class="title" itemprop="name">CHARGE Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Seema R Lalani</span>, MD, <span itemprop="author">Margaret A Hefner</span>, MS, <span itemprop="author">John W Belmont</span>, MD, PhD, and <span itemprop="author">Sandra LH Davenport</span>, MD, CM.</p><a data-jig="ncbitoggler" href="#__NBK1117_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1117_ai__"><div class="contrib half_rhythm"><span itemprop="author">Seema R Lalani</span>, MD<div class="affiliation small">Assistant Professor, Department of Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmt.mcb@lamees" class="oemail">ude.cmt.mcb@lamees</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Margaret A Hefner</span>, MS<div class="affiliation small">Genetic Counselor and Clinical Associate Professor, Department of Pediatrics<br />Saint Louis University School of Medicine<br />Saint Louis, Missouri<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.uls@amrenfeh" class="oemail">ude.uls@amrenfeh</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">John W Belmont</span>, MD, PhD<div class="affiliation small">Professor, Department of Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmt.mcb@tnomlebj" class="oemail">ude.cmt.mcb@tnomlebj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sandra LH Davenport</span>, MD, CM<div class="affiliation small">Sensory Genetics/Neurodevelopment<br />Bloomington, Minnesota<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.nmu.ct@nevadhls" class="oemail">ude.nmu.ct@nevadhls</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 2, 2006</span>; Last Update: <span itemprop="dateModified">February 2, 2012</span>.</p><p><em>Estimated reading time: 29 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="charge.Summary" itemprop="description"><h2 id="_charge_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>CHARGE is a mnemonic for <i>c</i>oloboma, <i>h</i>eart defects, choanal <i>a</i>tresia, <i>r</i>etarded growth and development, <i>g</i>enital abnormalities, and <i>e</i>ar anomalies. CHARGE syndrome is characterized by the following:</p><ul><li class="half_rhythm"><div>Unilateral or bilateral coloboma of the iris, retina-choroid, and/or disc with or without microphthalmos (80%-90% of individuals)</div></li><li class="half_rhythm"><div>Unilateral or bilateral choanal atresia or stenosis (50%-60%)</div></li><li class="half_rhythm"><div>Cranial nerve dysfunction resulting in hyposmia or anosmia, unilateral or bilateral facial palsy (40%), impaired hearing, and/or swallowing problems (70%-90%)</div></li><li class="half_rhythm"><div>Abnormal outer ears, ossicular malformations, Mondini defect of the cochlea and absent or hypoplastic semicircular canals (&#x0003e;90%)</div></li><li class="half_rhythm"><div>Cryptorchidism in males and hypogonadotropic hypogonadism in both males and females</div></li><li class="half_rhythm"><div>Developmental delay</div></li><li class="half_rhythm"><div>Cardiovascular malformations (75%-85%)</div></li><li class="half_rhythm"><div>Growth deficiency (70%-80%)</div></li><li class="half_rhythm"><div>Orofacial clefts (15%-20%)</div></li><li class="half_rhythm"><div>Tracheoesophageal fistula (15%-20%)</div></li></ul><p>Neonates with CHARGE syndrome often have multiple life-threatening medical conditions. Feeding difficulties are a major cause of morbidity in all age groups.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CHARGE syndrome is based on clinical findings and temporal bone imaging. <i>CHD7</i>, encoding the chromodomain helicase DNA binding protein, is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> currently known to be associated with CHARGE syndrome. Sequence analysis of the <i>CHD7</i> <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> detects pathogenic variants in most individuals with typical CHARGE syndrome (i.e., having the four major characteristics or three major and three minor characteristics). Overall, <i>CHD7</i> analysis in individuals with either typical CHARGE syndrome or a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (i.e., fewer major characteristics) detects pathogenic variants in about 65%-70% of cases.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Neonates require immediate evaluation of the airway, feeding, heart, and hearing. Management involves: tracheostomy and surgical correction of choanal atresia as needed; a multidisciplinary approach to feeding therapy including specialists in speech-language pathology, occupational therapy, and nutrition and gastrostomy as needed; routine care for heart defects; and hearing aids and hearing habilitation as soon as hearing loss is documented. Psychological/school evaluations should be performed by a team that includes specialists in deaf/blindness when dual sensory loss is present.</p><p><i>Prevention of secondary complications:</i> Special attention to potential airway problems associated with anesthesia.</p><p><i>Surveillance</i>: Regular ophthalmologic and audiologic evaluations; testing for hypogonadotropic hypogonadism if puberty has not occurred by age 13-14 years.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CHARGE syndrome, caused by mutation of <i>CHD7,</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with CHARGE syndrome represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family). If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has CHARGE syndrome or has a <i>CHD7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the pathogenic variant is 50%. If neither parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the empiric risk to sibs of a proband is approximately 1%-2%, most likely attributable to <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Prenatal diagnosis for pregnancies at increased risk is possible if the <i>CHD7</i> pathogenic variant has been identified in an affected family member.</p></div></div><div id="charge.Diagnosis"><h2 id="_charge_Diagnosis_">Diagnosis</h2><div id="charge.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>Diagnostic criteria for CHARGE syndrome, a multiple malformation syndrome, are based on a combination of major and minor diagnostic characteristics. (CHARGE stands for <i>c</i>oloboma, <i>h</i>eart defects, choanal <i>a</i>tresia, <i>r</i>etarded growth and development, <i>g</i>enital abnormalities, and <i>e</i>ar anomalies.)</p><p>As described by <a class="bk_pop" href="#charge.REF.blake.1998.159">Blake et al [1998]</a>, and modified by <a class="bk_pop" href="#charge.REF.amiel.2001.124">Amiel et al [2001]</a> and <a class="bk_pop" href="#charge.REF.verloes.2005.306">Verloes [2005]</a>, the major diagnostic characteristics of CHARGE syndrome are the following:</p><ul><li class="half_rhythm"><div><b>Definite CHARGE syndrome.</b> Individuals with all four major characteristics (<a class="figpopup" href="/books/NBK1117/table/charge.T.major_diagnostic_characteristic/?report=objectonly" target="object" rid-figpopup="figchargeTmajordiagnosticcharacteristic" rid-ob="figobchargeTmajordiagnosticcharacteristic">Table 1</a>) or three major and three minor characteristics (<a class="figpopup" href="/books/NBK1117/table/charge.T.minor_diagnostic_characteristic/?report=objectonly" target="object" rid-figpopup="figchargeTminordiagnosticcharacteristic" rid-ob="figobchargeTminordiagnosticcharacteristic">Table 2</a>)</div></li><li class="half_rhythm"><div><b>Probable/possible CHARGE syndrome.</b> Individuals with one or two major characteristics and several minor characteristics</div></li></ul><p><b>Major characteristics</b> are those that are common in CHARGE syndrome and relatively uncommon in other syndromes (see <a class="figpopup" href="/books/NBK1117/table/charge.T.major_diagnostic_characteristic/?report=objectonly" target="object" rid-figpopup="figchargeTmajordiagnosticcharacteristic" rid-ob="figobchargeTmajordiagnosticcharacteristic">Table 1</a>).</p><div id="charge.T.major_diagnostic_characteristic" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Major Diagnostic Characteristics of CHARGE Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1117/table/charge.T.major_diagnostic_characteristic/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__charge.T.major_diagnostic_characteristic_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Characteristics</th><th id="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestations</th><th id="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ocular coloboma</td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Coloboma of the iris, retina, choroid, disc; microphthalmos</td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">80%-90%</td></tr><tr><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Choanal atresia or stenosis&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unilateral/bilateral: bony or membranous atresia/stenosis</td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50%-60%</td></tr><tr><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Cranial nerve dysfunction or anomaly</td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">I: hyposmia or anosmia</td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent</td></tr><tr><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">VII: facial palsy (unilateral or bilateral)</td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;40%</td></tr><tr><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">VIII: hypoplasia of auditory nerve</td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent</td></tr><tr><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">IX/X: swallowing problems with aspiration</td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70%-90%</td></tr><tr><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Characteristic CHARGE syndrome ear</td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Outer ear: short, wide ear with little or no lobe, "snipped off" helix, prominent antihelix that is often discontinuous with tragus, triangular concha, decreased cartilage; often protruding and usually asymmetric (see <a class="figpopup" href="/books/NBK1117/figure/charge.F1/?report=objectonly" target="object" rid-figpopup="figchargeF1" rid-ob="figobchargeF1">Figure 1</a>)&#x000a0;<sup>3</sup></td><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">80%-100%</td></tr><tr><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Middle ear: ossicular malformations&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Mondini defect of the cochlea&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_charge.T.major_diagnostic_characteristic_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Temporal bone abnormalities; absent or hypoplastic semicircular canals&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="charge.TF.1.1"><p class="no_margin">Cleft palate may substitute for this characteristic in some individuals.</p></div></dd><dt>2. </dt><dd><div id="charge.TF.1.2"><p class="no_margin">The diagnosis is confirmed by non-enhanced CT scan in axial sections.</p></div></dd><dt>3. </dt><dd><div id="charge.TF.1.3"><p class="no_margin"><a class="bk_pop" href="#charge.REF.davenport.1986b.137">Davenport et al [1986b]</a></p></div></dd><dt>4. </dt><dd><div id="charge.TF.1.4"><p class="no_margin">The combination of ossicular malformations and inner ear defects can result in a mixed (conductive and sensorineural) hearing loss with a wedge-shaped audiogram.</p></div></dd><dt>5. </dt><dd><div id="charge.TF.1.5"><p class="no_margin">Most commonly determined by CT of the temporal bones</p></div></dd></dl></div></div></div><div id="charge.F1" class="figure bk_fig"><div class="graphic"><img src="/books/NBK1117/bin/charge-Image001.jpg" alt="Figure 1. " /></div><h3><span class="label">Figure 1. </span></h3><div class="caption"><p>Ears</p><p>1a. Clipped-off helix, prominent antihelix that extends to the outer helical rim, antihelix discontinuous with the antitragus; absent lobe</p><p>1b. Antihelix discontinuous with the antitragus; very small lobe. Preauricular tag occurs occasionally.</p><p>1c. Clipped off helix, prominent antihelix that extends to helical margin and does not connect with antitragus, triangular concha and absent lobe</p><p>1d. Thin, unfolded helix, prominent inferior antihelix with notch between it and antitragus, rudimentary lobe</p></div></div><p><b>Minor characteristics</b> are common in CHARGE syndrome but are either less specific to CHARGE syndrome (e.g., heart defects), more difficult to evaluate consistently (e.g., characteristic CHARGE syndrome face), or not readily apparent in infancy (see <a class="figpopup" href="/books/NBK1117/table/charge.T.minor_diagnostic_characteristic/?report=objectonly" target="object" rid-figpopup="figchargeTminordiagnosticcharacteristic" rid-ob="figobchargeTminordiagnosticcharacteristic">Table 2</a>).</p><div id="charge.T.minor_diagnostic_characteristic" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Minor Diagnostic Characteristics of CHARGE Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1117/table/charge.T.minor_diagnostic_characteristic/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__charge.T.minor_diagnostic_characteristic_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Characteristics</th><th id="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestations</th><th id="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Genital hypoplasia</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Males: micropenis, cryptorchidism<br />Females: hypoplastic labia</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50%-60%</td></tr><tr><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Males and females: delayed puberty secondary to hypogonadotropic hypogonadism</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent</td></tr><tr><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental delay&#x000a0;<sup>1</sup></td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Delayed milestones, hypotonia</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;100%</td></tr><tr><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiovascular malformation</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Including conotruncal defects (e.g., tetralogy of Fallot), AV canal defects, and aortic arch anomalies</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">75%-85%</td></tr><tr><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Growth deficiency</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Short stature, usually postnatal with or without growth hormone deficiency</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70%-80%</td></tr><tr><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orofacial cleft</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cleft lip and/or palate</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%-20%</td></tr><tr><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tracheoesophageal (TE) fistula</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">TE defects of all types</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%-20%</td></tr><tr><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinctive facial features</td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Square face with broad prominent forehead, prominent nasal bridge and columella, flat midface (see <a class="figpopup" href="/books/NBK1117/figure/charge.F2/?report=objectonly" target="object" rid-figpopup="figchargeF2" rid-ob="figobchargeF2">Figure 2</a>)&#x000a0;<sup>2</sup></td><td headers="hd_h_charge.T.minor_diagnostic_characteristic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70%-80%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="charge.TF.2.1"><p class="no_margin">May be primarily the result of illness, dual sensory impairment, and vestibular dysfunction</p></div></dd><dt>2. </dt><dd><div id="charge.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#charge.REF.davenport.1986a.298">Davenport et al [1986a]</a></p></div></dd></dl></div></div></div><div id="charge.F2" class="figure bk_fig"><div class="graphic"><img src="/books/NBK1117/bin/charge-Image002.jpg" alt="Figure 2. " /></div><h3><span class="label">Figure 2. </span></h3><div class="caption"><p>Face</p><p>2a. Female age 2 1/2 years; square face, round eye, straight nose with broad nasal root, unilateral facial palsy</p><p>2b. Female age five years; mild expression of CHARGE facies; relatively square face, prominent columella of the nose. Note sloping shoulders.</p><p>2c. Male age seven years; square face, somewhat broad nasal root. Note prominent ear with unfolded helix and wide neck.</p><p>2d. Female age nine years; square face, round eyes, wide neck, sloping shoulders. Note lack of facial expression as a result of bilateral facial palsy.</p><p>2e. Male age 15 years. Note longer but still somewhat square face, wide neck with sloping shoulders.</p><p>2f. Female age 18 years; square, asymmetric face, prominent ears, head tilted back, wide neck, and sloping shoulders</p></div></div><p>Occasional findings include the following:</p><ul><li class="half_rhythm"><div>DiGeorge sequence</div></li><li class="half_rhythm"><div>Omphalocele or umbilical hernia</div></li><li class="half_rhythm"><div>Bony scoliosis or hemivertebrae</div></li><li class="half_rhythm"><div>Renal anomalies including dysgenesis, horseshoe/ectopic kidney</div></li><li class="half_rhythm"><div>Hand anomalies including polydactyly, altered palmar flexion creases (see <a class="figpopup" href="/books/NBK1117/figure/charge.F3/?report=objectonly" target="object" rid-figpopup="figchargeF3" rid-ob="figobchargeF3">Figure 3</a>), atypical split hand/split foot deformity</div></li><li class="half_rhythm"><div>Additional features including short webbed neck, sloping shoulders, and nipple anomalies</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figchargeF3" co-legend-rid="figlgndchargeF3"><a href="/books/NBK1117/figure/charge.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figchargeF3" rid-ob="figobchargeF3"><img class="small-thumb" src="/books/NBK1117/bin/charge-Image003.gif" src-large="/books/NBK1117/bin/charge-Image003.jpg" alt="Figure 3. " /></a><div class="icnblk_cntnt" id="figlgndchargeF3"><h4 id="charge.F3"><a href="/books/NBK1117/figure/charge.F3/?report=objectonly" target="object" rid-ob="figobchargeF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Typical CHARGE hand: square hand, short fingers, finger-like thumb, hockey-stick palmar crease </p></div></div></div><div id="charge.Testing"><h3>Testing</h3><p><b>Cytogenetic analysis.</b> The majority of individuals with CHARGE syndrome have a normal <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>; on rare occasions, variable <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormalities are seen. The following chromosome abnormalities that disrupt <i>CHD7</i> (<a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> 8q12) have been reported:</p><ul><li class="half_rhythm"><div>Balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> t(6;8)(6p8p;6q8q) [<a class="bk_pop" href="#charge.REF.hurst.1991.54">Hurst et al 1991</a>]</div></li><li class="half_rhythm"><div><i>De novo</i> balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement t(8;13)(q11.2;q22) [<a class="bk_pop" href="#charge.REF.johnson.2006.280">Johnson et al 2006</a>]</div></li><li class="half_rhythm"><div>Interstitial <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 8q11.2-q13 [<a class="bk_pop" href="#charge.REF.arrington.2005.326">Arrington et al 2005</a>]</div></li></ul><div id="charge.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>CHD7</i>, encoding the chromodomain helicase DNA-binding protein, is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause CHARGE syndrome [<a class="bk_pop" href="#charge.REF.vissers.2004.955">Vissers et al 2004</a>].</p><div id="charge.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in CHARGE Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1117/table/charge.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__charge.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHD7</i></td><td headers="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;90% in typical cases fulfilling Blake's diagnostic criteria&#x000a0;<sup>5</sup><br />65%-70% for all typical and suspected cases combined&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing&#x000a0;<sup>7</sup></td><td headers="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Large contiguous-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions; <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions</td><td headers="hd_h_charge.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="charge.TF.3.1"><p class="no_margin">See <a href="/books/NBK1117/#charge.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="charge.TF.3.2"><p class="no_margin">See <a href="#charge.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="charge.TF.3.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="charge.TF.3.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="charge.TF.3.5"><p class="no_margin"><a class="bk_pop" href="#charge.REF.bergman.2011.334">Bergman et al [2011]</a></p></div></dd><dt>6. </dt><dd><div id="charge.TF.3.6"><p class="no_margin"><a class="bk_pop" href="#charge.REF.jongmans.2006.306">Jongmans et al [2006]</a>, <a class="bk_pop" href="#charge.REF.aramaki.2006.410">Aramaki et al [2006]</a>, <a class="bk_pop" href="#charge.REF.zentner.2010.674">Zentner et al [2010]</a></p></div></dd><dt>7. </dt><dd><div id="charge.TF.3.7"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA; included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>8. </dt><dd><div id="charge.TF.3.8"><p class="no_margin"><a class="bk_pop" href="#charge.REF.aramaki.2006.410">Aramaki et al [2006]</a>, <a class="bk_pop" href="#charge.REF.vuorela.2007.690">Vuorela et al [2007]</a>. In 54 individuals in whom no <i>CHD7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="bk_pop" href="#charge.REF.bergman.2008.417">Bergman et al [2008]</a> found <i>CHD7</i> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions in one individual (1.9%).</p></div></dd></dl></div></div></div></div></div><div id="charge.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis is primarily established by clinical findings. Molecular testing for <i>CHD7</i> confirms the diagnosis in the majority of cases.</p><ul><li class="half_rhythm"><div>Sequence analysis is the first test of choice.</div></li><li class="half_rhythm"><div>If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> by a variety of methods (see <a class="figpopup" href="/books/NBK1117/table/charge.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figchargeTmoleculargenetictestingused" rid-ob="figobchargeTmoleculargenetictestingused">Table 3</a>, footnote 7) can be performed to identify large contiguous-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions and <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions.</div></li></ul><p>Array CGH study can be considered to exclude <a href="/books/n/gene/gr_22q11deletion/">22q11.2 deletion</a> and other <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> abnormalities, with associated <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> overlapping with CHARGE syndrome.</p><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p></div></div><div id="charge.Clinical_Characteristics"><h2 id="_charge_Clinical_Characteristics_">Clinical Characteristics</h2><div id="charge.Clinical_Description"><h3>Clinical Description</h3><p><b>Morbidity and mortality.</b> Neonates with CHARGE syndrome often have multiple life-threatening medical conditions. <a class="bk_pop" href="#charge.REF.blake.1990.217">Blake et al [1990]</a> reported poor survival if one or more of the following were present: cyanotic cardiac lesions, bilateral posterior choanal atresia, and tracheoesophageal fistula. In another study, poor life expectancy correlated with male gender, central nervous system (CNS) malformation, bilateral choanal atresia, and tracheoesophageal fistula [<a class="bk_pop" href="#charge.REF.tellier.1998.402">Tellier et al 1998</a>]. <a class="bk_pop" href="#charge.REF.issekutz.2005.309">Issekutz et al [2005]</a> reported high mortality in infants with atrioventricular septal defects and in infants with a combination of ventriculomegaly and brain stem/cerebellar anomalies (13%). Feeding difficulties were also found to be a major cause of morbidity at all ages.</p><p><b>Choanal atresia.</b> At birth, bilateral choanal atresia causes respiratory distress requiring immediate resuscitation. Unilateral choanal atresia may go undiagnosed until the child presents with persistent unilateral rhinorrhea.</p><p><b>Heart defects</b> are present in 75%-85% of individuals with CHARGE syndrome and are often complex. Many types of heart defects occur; conotruncal anomalies (tetralogy of Fallot, interrupted aortic arch, perimembranous ventricular septal defect, double-outlet right ventricle, and truncus arteriosus), AV canal defects, and aortic arch anomalies (vascular ring, aberrant subclavian artery) are described frequently. Other common structural defects include ASD, VSD, and PDA.</p><p><b>Esophageal atresia or tracheoesophageal fistula</b> occurs in approximately 15%-20% of infants with CHARGE syndrome and can further exacerbate feeding difficulties and respiratory distress in the first few days of life. Preoperatively, the greatest risk to the infant is aspiration. Early diagnosis with appropriate clinical management greatly improves survival.</p><p><b>Swallowing problems.</b> Feeding can be associated with coughing, choking, nasal regurgitation, aspiration, and/or gastroesophageal reflux [<a class="bk_pop" href="#charge.REF.dobbelsteyn.2005.89">Dobbelsteyn et al 2005</a>]. Aspiration and swallowing dysfunction are common in children with CHARGE syndrome and are primarily the result of cranial nerve IX/X abnormalities often complicated by choanal atresia or cleft palate.</p><p>Flexible endoscopic evaluation of swallowing (FEES) and/or video swallow study (VSS) often show pooling, premature spillage, poor hypopharyngeal motility, or laryngeal penetration [<a class="bk_pop" href="#charge.REF.white.2005.1205">White et al 2005</a>]. A large number of children require nasogastric or gastric (G-tube) feeding, often for several years. Swallowing may eventually improve spontaneously; however, some adults continue to avoid foods that are difficult to swallow.</p><p>Gastroesophageal reflux is common.</p><p><b>Airway</b> problems are primarily the result of a structural defect such as choanal atresia but can also be secondary to aspiration of gastric contents caused by swallowing incoordination and gastroesophageal reflux. Without interventions such as Nissen fundoplication and gastrostomy and tracheostomy, recurrent pneumonia and long-term lung damage can result.</p><p><b>Facial palsy.</b> Unilateral or bilateral facial palsy is present in almost 50% of individuals with CHARGE syndrome. Bilateral facial palsy results in lack of facial expression, which may hinder interpersonal communication.</p><p><b>Colobomata</b> are found in one or both eyes in 80%-90% of individuals with CHARGE syndrome. Asymmetry in the size and extent of involvement of the eyes is frequent. Iris colobomas do not interfere with vision but may predispose to light sensitivity. A uveo-retinal coloboma commonly extends posteriorly to the optic nerve, which may be severely dysplastic and reduce vision. The macula may be involved, most commonly in eyes that are moderately to severely microphthalmic, further compromising vision. Any uveo-retinal coloboma increases the risk of retinal detachment because of the thin marginal adhesion to the edge of the retinal pigment epithelium.</p><p><b>Hearing loss</b> is one of the most common features of CHARGE syndrome. Hearing loss can vary from mild to profound (see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>). The hearing loss can be difficult to quantify, requiring multiple brain stem audio evoked response (BAER) tests over several months. <a class="bk_pop" href="#charge.REF.thelin.1986.145">Thelin et al [1986]</a> reported a characteristic wedge-shaped audiometric pattern of mixed hearing loss and verified that hearing loss is progressive in some individuals [<a class="bk_pop" href="#charge.REF.thelin.2005.282">Thelin &#x00026; Fussner 2005</a>]. The presence of facial paralysis was found to predict reliably the presence of sensorineural hearing loss [<a class="bk_pop" href="#charge.REF.edwards.2002.119">Edwards et al 2002</a>].</p><p>The <b>sensorineural</b> component of the hearing loss is often associated with a Mondini malformation of the cochlea. Hypoplasia of the auditory nerve has also been described.</p><p>The <b>conductive</b> component of the hearing loss may result from malformed or absent ossicles, fixation of the ossicular chain to the wall of the tympanic cavity, absence of the stapedius muscle, absence of the oval window, and obliteration of the round window [<a class="bk_pop" href="#charge.REF.dhooge.1998.935">Dhooge et al 1998</a>, <a class="bk_pop" href="#charge.REF.morimoto.2006.1663">Morimoto et al 2006</a>]. The conductive component may fluctuate with middle ear disease.</p><p>Chronic recurrent otitis media is common.</p><p><b>Vestibular abnormalities.</b> With appropriate imaging, abnormalities of the semicircular canals are found in as many as 95% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#charge.REF.lemmerling.1998.462">Lemmerling et al 1998</a>, <a class="bk_pop" href="#charge.REF.tellier.1998.402">Tellier et al 1998</a>, <a class="bk_pop" href="#charge.REF.wienervacher.1999.342">Wiener-Vacher et al 1999</a>, <a class="bk_pop" href="#charge.REF.abadie.2000.569">Abadie et al 2000</a>, <a class="bk_pop" href="#charge.REF.bauer.2002.1013">Bauer et al 2002</a>, <a class="bk_pop" href="#charge.REF.morimoto.2006.1663">Morimoto et al 2006</a>].</p><p>Absence or hypoplasia of the semicircular canals impairs balance, especially when combined with visual loss. The resulting poor balance contributes to delays in motor development.</p><p><b>Genitourinary abnormalities.</b> Approximately 50%-60% of males have genital hypoplasia manifesting as micropenis and cryptorchidism. <a class="bk_pop" href="#charge.REF.wheeler.2000.228">Wheeler et al [2000]</a> suggested that central hypogonadism is responsible not only for the genital hypoplasia in males, but also for the lack of secondary sexual development in both males and females. Hypogonadotropic hypogonadism, evidenced by lack of pubertal development and/or abnormally low serum concentrations of LH and FSH, was reported in all nine individuals in this study.</p><p>Renal anomalies, including solitary kidney, hydronephrosis, and renal hypoplasia, occur in approximately 25%-40% of children with CHARGE syndrome [<a class="bk_pop" href="#charge.REF.blake.1998.159">Blake et al 1998</a>, <a class="bk_pop" href="#charge.REF.ragan.1999.622">Ragan et al 1999</a>].</p><p><b>Growth retardation.</b> Children with CHARGE syndrome usually have normal birth weight and birth length. By late infancy, linear growth usually declines from the normal curve.</p><p>In a study of 25 children with normal nutritional status age five years and older, <a class="bk_pop" href="#charge.REF.pinto.2005.5621">Pinto et al [2005]</a> reported normal growth hormone (GH) secretion in 22 and GH deficiency in three. The three with GH deficiency had height more than 3 SD below the mean, growth rate less than 4 cm/year, insufficient response to two GH stimulation tests, and IGF-I levels greater than 2 SD below the mean for age and pubertal stage.</p><p><b>Immunodeficiency.</b> DiGeorge sequence can be occasionally seen in CHARGE syndrome, resulting in mild to severe T-cell deficiency [<a class="bk_pop" href="#charge.REF.writzl.2007.338">Writzl et al 2007</a>].</p><p><b>Limb/bone abnormalities.</b> Limb abnormalities are observed in more than one third of individuals with CHARGE syndrome [<a class="bk_pop" href="#charge.REF.brock.2003.111">Brock et al 2003</a>]. Although no consistent pattern is observed, the more commonly reported anomalies include hypoplastic nails, clinodactyly (fifth finger, second toe), polydactyly, contractures, brachydactyly, missing digits, clubfoot, tibial anomalies, and joint hyperflexibility. Hip dislocation, missing ribs, and abnormal vertebrae have also been described.</p><p><b>Scoliosis</b> is common [<a class="bk_pop" href="#charge.REF.doyle.2005.340">Doyle &#x00026; Blake 2005</a>]. During childhood, it is often neuromuscular in origin.</p><p><b>Dental</b> anomalies include protruding jaw, overbite, hypodontia of permanent dentition, and poor mineralization of the enamel [<a class="bk_pop" href="#charge.REF.str_mland.2005.331">Str&#x000f6;mland et al 2005</a>].</p><p><b>Sinusitis</b> may be a major problem in childhood and in older children is often caused by "silent" gastroesophageal reflux. Sinusitis is a frequent cause of severe pain, often manifested by sudden changes in behavior, including apparently aggressive behaviors.</p><p><b>Brain abnormalities.</b> Reported central nervous system anomalies include arrhinencephaly, corpus callosum agenesis and posterior fossa anomalies [<a class="bk_pop" href="#charge.REF.tellier.1998.402">Tellier et al 1998</a>]. Anomalies of the olfactory tracts and bulbs varying from moderate hypoplasia to complete aplasia causing olfactory deficiency have been reported in numerous studies [<a class="bk_pop" href="#charge.REF.chalouhi.2005.e81">Chalouhi et al 2005</a>, <a class="bk_pop" href="#charge.REF.pinto.2005.5621">Pinto et al 2005</a>].</p><p>The course of the facial nerve is often anomalous [<a class="bk_pop" href="#charge.REF.morimoto.2006.1663">Morimoto et al 2006</a>].</p><p><b>Developmental delay.</b> Children with CHARGE syndrome usually show marked delays in motor development. Prolonged hospitalization, truncal hypotonia with ligamentous laxity, decreased visual acuity, hearing impairment, and vestibular disturbance all contribute to this delay. Many infants show poor head control and often move using a combat crawl, pushing with their feet in the supine position or by using a five-point crawl (using the head for additional support). When walking is initiated, gait is often unsteady.</p><p>In one report, mean age for head holding was five months, sitting independently 14.8 months, and walking unaided 33 months [<a class="bk_pop" href="#charge.REF.tellier.1998.402">Tellier et al 1998</a>].</p><p><b>Speech/language delay.</b> Language development is often delayed because of hearing loss and further exacerbated by reduced vision that impairs lip reading and perception of body language cues.</p><p><b>Cognitive development and psychological assessment.</b> Delayed motor and/or language development cannot be used to predict cognitive potential of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#charge.REF.raqbi.2003.483">Raqbi et al 2003</a>, <a class="bk_pop" href="#charge.REF.brown.2005.268">Brown 2005</a>, <a class="bk_pop" href="#charge.REF.hartshorne.2005b.228">Hartshorne et al 2005b</a>].</p><p>Assessment of cognitive abilities is difficult because of lack of standardized tools to evaluate individuals with both visual and hearing impairment. <a class="bk_pop" href="#charge.REF.raqbi.2003.483">Raqbi et al [2003]</a> showed that the intellectual performance of individuals with CHARGE syndrome ranged from major learning disability with no speech and poor communication to almost normal. They demonstrated that despite marked delay in motor milestones in children ages birth to three years, intellectual outcome in 50% was satisfactory. Only 25% of the studied group had a poor intellectual outcome. <a class="bk_pop" href="#charge.REF.raqbi.2003.483">Raqbi et al [2003]</a> also showed that microcephaly, brain malformation, and extensive bilateral coloboma resulting in reduced vision were the only findings predictive of poor intellectual outcome. The results suggest that for approximately half of children with CHARGE syndrome, motor and speech/language delay is mainly secondary to multiple sensory deficits and not to CNS dysfunction.</p><p><a class="bk_pop" href="#charge.REF.salemhartshorne.2005.262">Salem-Hartshorne &#x00026; Jacob [2005]</a> showed that the range of adaptive behavior scores (ABES) in individuals with CHARGE syndrome is broader and higher than previously reported. Those children with better walking skills and fewer medical problems scored higher on this scale than children with poorer walking skills and more medical problems. In this study, one half of the individuals obtained a standard score higher than 70 on the ABES at follow up; 13% scored above a standard score of 90.</p><p>Many adults with CHARGE syndrome are known to live independently and many are currently attending college, or are college graduates with advanced degrees [<a class="bk_pop" href="#charge.REF.hartshorne.2005b.228">Hartshorne et al 2005b</a>; Hefner &#x00026; Davenport, personal observations].</p><p><b>Behavioral profile</b> includes repetitive, obsessive-compulsive, aggressive, and self-abusive behaviors [<a class="bk_pop" href="#charge.REF.bernstein.2005.232">Bernstein &#x00026; Denno 2005</a>, <a class="bk_pop" href="#charge.REF.hartshorne.2005a.257">Hartshorne et al 2005a</a>, <a class="bk_pop" href="#charge.REF.hartshorne.2005b.228">Hartshorne et al 2005b</a>, <a class="bk_pop" href="#charge.REF.smith.2005.248">Smith et al 2005</a>]. Attention-deficit hyperactivity disorder (ADHD) is also seen in many individuals with CHARGE syndrome [<a class="bk_pop" href="#charge.REF.hartshorne.2004.41">Hartshorne &#x00026; Cypher 2004</a>]. Many behaviors regarded as aberrant or disruptive are attempts at communication about pain, unease, or frustration [<a class="bk_pop" href="#charge.REF.brown.2005.268">Brown 2005</a>, <a class="bk_pop" href="#charge.REF.salemhartshorne.2005.262">Salem-Hartshorne &#x00026; Jacob 2005</a>].</p></div><div id="charge.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No clear <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> exist [<a class="bk_pop" href="#charge.REF.jongmans.2006.306">Jongmans et al 2006</a>, <a class="bk_pop" href="#charge.REF.lalani.2006.303">Lalani et al 2006</a>, <a class="bk_pop" href="#charge.REF.sanlaville.2006.211">Sanlaville et al 2006</a>].</p><p>Most individuals with the combination of coloboma, choanal atresia, and hypoplastic semicircular canals (three major signs identified by <a class="bk_pop" href="#charge.REF.verloes.2005.306">Verloes [2005]</a>) have pathogenic variants in <i>CHD7</i> [<a class="bk_pop" href="#charge.REF.lalani.2006.303">Lalani et al 2006</a>, <a class="bk_pop" href="#charge.REF.jongmans.2006.306">Jongmans et al 2006</a>].</p></div><div id="charge.Penetrance"><h3>Penetrance</h3><p>To date, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in those with <i>CHD7</i> pathogenic variants is 100%: all individuals who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>CHD7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have some features of CHARGE syndrome.</p></div><div id="charge.Nomenclature"><h3>Nomenclature</h3><p>For individuals who fit the diagnostic criteria for CHARGE syndrome or have <i>CHD7</i> pathogenic variants, "CHARGE association" is not an appropriate term.</p><p>Although the earliest descriptions of what is now known as CHARGE syndrome were published by Hall and Hittner, the term "Hall-Hittner syndrome" has not been a common designation for this syndrome.</p></div><div id="charge.Prevalence"><h3>Prevalence</h3><p>CHARGE syndrome occurs in at least one in 10,000 births. <a class="bk_pop" href="#charge.REF.issekutz.2005.309">Issekutz et al [2005]</a> suggest occurrence in one in 8,500 births.</p><p>No teratogen or exposure is known to increase the risk for CHARGE syndrome.</p></div></div><div id="charge.Genetically_Related_Allelic_Disor"><h2 id="_charge_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p><a class="bk_pop" href="#charge.REF.gao.2007.957">Gao et al [2007]</a> reported polymorphisms in <i>CHD7</i>, associated with susceptibility to <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> scoliosis.</p></div><div id="charge.Differential_Diagnosis"><h2 id="_charge_Differential_Diagnosis_">Differential Diagnosis</h2><p><a href="/books/n/gene/gr_22q11deletion/"><b>The 22q11.2 deletion syndrome</b></a> (del 22q11.2) is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease, particularly conotruncal malformations (tetralogy of Fallot, interrupted aortic arch type IB, perimembranous ventricular septal defect, double outlet right ventricle, and truncus arteriosus); palatal abnormalities, particularly velopharyngeal incompetence (VPI), submucosal cleft palate, and cleft palate; characteristic facial features; and learning difficulties. Additional findings include immune deficiency, hypocalcemia, significant feeding problems, renal anomalies, hearing loss (both conductive and sensorineural), laryngotracheoesophageal anomalies, growth hormone deficiency, autoimmune disorders, seizures (without hypocalcemia), and skeletal abnormalities. The 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> is diagnosed in individuals with a submicroscopic deletion of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 detected by fluorescence in situ hybridization (<a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>) using DNA probes from the DiGeorge chromosome region (DGCR).</p><p>Several clinical features of 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> overlap with CHARGE syndrome; however, the facial features seen in these disorders are distinct. Abnormalities of the semicircular canals that are common in CHARGE syndrome are rarely seen in 22q11.2 deletion syndrome. Feeding difficulties typically last longer in children with CHARGE syndrome than 22q11.2 deletion syndrome.</p><p><a href="/books/n/gene/kms/"><b>Kallmann syndrome</b></a><b>.</b> Although pathogenic variants in <i>CHD7</i> have been reported in individuals with Kallmann syndrome (hypogonadotropic hypogonadism and anosmia or hyposmia), these individuals have additional features characteristic of CHARGE syndrome and thus, CHARGE syndrome is the most appropriate diagnosis for such individuals [<a class="bk_pop" href="#charge.REF.jongmans.2008.43">Jongmans et al 2008</a>].</p><p><b>VACTERL association</b> is a combination of <i>v</i>ertebral anomalies, <i>a</i>nal atresia, <i>c</i>ardiac anomalies, <i>t</i>racheo<i>e</i>sophageal fistula or esophageal atresia, and <i>r</i>enal and <i>l</i>imb anomalies. VACTERL association generally differs from CHARGE syndrome by the absence of colobomas, choanal atresia, characteristic ear deformity, and cranial nerve anomalies. The temporal bone anomaly frequently seen in CHARGE syndrome is rarely reported in VACTERL. VACTERL usually occurs sporadically. The cause is unknown.</p><p><a href="/books/n/gene/kabuki/"><b>Kabuki syndrome</b></a><b>.</b>
<a class="bk_pop" href="#charge.REF.ming.2003.249">Ming et al [2003]</a> reported that phenotypic overlap between CHARGE syndrome and Kabuki syndrome (cleft palate, heart defects, occasional coloboma, growth retardation) can sometimes lead to the consideration of CHARGE syndrome in individuals with Kabuki syndrome. However, the typical facial features in Kabuki syndrome (long palpebral fissures with eversion of lateral third of lower eyelids, sparse eyebrows, and large prominent ears (all of which become more prominent with age) and prominent fingertip pads are distinct from those in CHARGE syndrome. A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MLL2</i> is identified in about 56%-76% of individuals with a clinical diagnosis of Kabuki syndrome [<a class="bk_pop" href="#charge.REF.hannibal.2011.1511">Hannibal et al 2011</a>, <a class="bk_pop" href="#charge.REF.li.2011.715">Li et al 2011</a>, <a class="bk_pop" href="#charge.REF.micale.2011.38">Micale et al 2011</a>, <a class="bk_pop" href="#charge.REF.paulussen.2011.e2018">Paulussen et al 2011</a>].</p><p><a href="/books/n/gene/papr/"><b>Renal coloboma syndrome</b></a> (papillorenal syndrome), caused by pathogenic variants in <i>PAX2</i>, is characterized by retinal/optic nerve colobomas, kidney abnormalities, and occasional hearing loss. Individuals with a <i>PAX2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> do not have the multiple <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies seen in CHARGE syndrome. No individual with a clinical diagnosis of CHARGE syndrome has been found to have a pathogenic variant in <i>PAX2</i> [<a class="bk_pop" href="#charge.REF.tellier.2000.85">Tellier et al 2000</a>].</p><p><b>Cat-eye syndrome,</b> characterized by the combination of coloboma of the iris and anal atresia with fistula, preauricular tags and/or pits, and frequent occurrence of heart and renal malformations, is caused by inv dup(22)(q11) (presence of a supernumerary bisatellited <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 that often has two centromeres). Individuals with cat-eye syndrome do not fulfill the clinical diagnostic criteria for CHARGE syndrome.</p><p><a href="/books/n/gene/joubert/"><b>Joubert syndrome</b></a> with bilateral chorioretinal coloboma is characterized by interstitial fibrosis of the kidney leading to renal insufficiency, hepatic fibrosis, neonatal tachypnea, cerebellar vermis aplasia/ hypoplasia, and polydactyly. "Molar tooth" sign on neuroimaging is diagnostic of Joubert syndrome. The characteristic radiologic features and the absence of other major diagnostic characteristics of CHARGE syndrome distinguish this condition from CHARGE syndrome. Pathogenic variants in at least ten genes are known to cause Joubert syndrome; inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><a href="/books/n/gene/bor/"><b>Branchiootorenal (BOR) syndrome</b></a><b>,</b> caused by mutation of <i>EYA1</i>, is a syndrome of deafness, external ear deformity, lateral semicircular canal hypoplasia, and renal malformation. The absence of branchial fistulae and cysts and other major criteria of CHARGE syndrome distinguish BOR syndrome from CHARGE syndrome.</p><p><b>Choanal atresia</b> can be an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> birth defect or occur as part of a syndrome. Other conditions in which choanal atresia occurs:</p><ul><li class="half_rhythm"><div>Chromosome abnormalities</div></li><li class="half_rhythm"><div>Craniosynostosis syndromes (see <a href="/books/n/gene/craniosynostosis/"><i>FGFR</i>-related craniosynostosis</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/tcs/">Treacher Collins syndrome</a></div></li><li class="half_rhythm"><div>Prenatal exposure to methimazole</div></li></ul><p><b>Retinoic embryopathy secondary to prenatal Accutane&#x02122; exposure.</b> Exposure to Accutane&#x02122; during any time within the first trimester produces malformations associated with abnormal migration of neural crest cells. Malformations include microtia/anotia, micrognathia, cleft palate, conotruncal heart defects and aortic-arch abnormalities, thymic defects, retinal or optic nerve abnormalities, and central nervous system malformations [<a class="bk_pop" href="#charge.REF.lammer.1985.837">Lammer et al 1985</a>]. Although some overlap, especially the conotruncal cardiac malformations, is seen with CHARGE syndrome, infants with retinoic embryopathy do not meet diagnostic criteria for CHARGE syndrome.</p></div><div id="charge.Management"><h2 id="_charge_Management_">Management</h2><div id="charge.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with CHARGE syndrome, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Dilated ophthalmologic examination by pediatric ophthalmologist to determine the type and extent of the coloboma and associated findings such as strabismus, refractive error, or central vision impairment (CVI); when possible, clinical testing of visual fields</div></li><li class="half_rhythm"><div>Cardiac evaluation for cardiovascular anomalies</div></li><li class="half_rhythm"><div>Assessment for unilateral or bilateral choanal atresia and/or stenosis by nasal endoscopy or CT scan</div></li><li class="half_rhythm"><div>ENT and audiologic evaluation:</div><ul><li class="half_rhythm"><div>In infants, brain stem auditory evoked response (BAER) to evaluate hearing as soon as the infant is medically stable</div></li><li class="half_rhythm"><div>In older children and adults, hearing evaluation as appropriate for age and developmental status</div></li><li class="half_rhythm"><div>See <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a> for discussion of types of audiologic evaluation.</div></li></ul></li><li class="half_rhythm"><div>CT scan of the temporal bones to evaluate for middle ear and inner ear defects</div></li><li class="half_rhythm"><div>Evaluation for cleft palate, including submucous cleft palate</div></li><li class="half_rhythm"><div>Assessment of cranial nerve function by physical examination for evidence of facial palsy and by swallowing studies</div></li><li class="half_rhythm"><div>Evaluation for esophageal atresia or tracheoesophageal (TE) fistula with posteroanterior and lateral plain chest radiographs and radiographic visualization of a rigid nasogastric tube that fails to pass from the mouth to the stomach (Contrast-enhanced studies may be necessary to identify or locate a fistula.)</div></li><li class="half_rhythm"><div>Renal ultrasound examination</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="charge.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management of children with CHARGE syndrome requires coordinated multidisciplinary care:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Airway</b> can be compromised from choanal atresia, TE fistula, aspiration pneumonias, tracheomalacia, or an aberrant subclavian vessel impinging on the trachea. Studies have shown that 15%-60% of individuals with CHARGE syndrome require tracheostomy [<a class="bk_pop" href="#charge.REF.roger.1999.33">Roger et al 1999</a>, <a class="bk_pop" href="#charge.REF.white.2005.1205">White et al 2005</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Heart defects</b> are managed as in any individual with a <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defect.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Choanal atresia.</b> Surgical correction by means of transnasal, transpalatal, or sublabial routes or airway bypass by tracheotomy or endotracheal intubation is usually necessary early in life. Multiple surgeries are often required to maintain the nasal airway.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Feeding/swallowing dysfunction.</b> In infancy, feeding can be compromised by oral-motor and/or sensory deficits. A multidisciplinary approach to therapy with specialists in speech-language pathology, occupational therapy, and nutrition can help promote early oral exploration and prevent or minimize oral defensiveness. For children with a G-tube, oral stimulation needs to be maintained to reduce future oral sensitivity/aversion.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Gastroesophageal reflux</b> can be significant enough to cause aspiration, often requiring Nissen fundoplication and G-tube insertion. Silent reflux should be considered in the evaluation of recurrent sinusitis.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Renal evaluation.</b> Renal ultrasound examination is recommended in all children. Evaluation for urinary tract infection is recommended in cases of unexplained fever or irritability in children unable to communicate.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Endocrine evaluation.</b> Early referral for endocrinology consultation is appropriate, especially if linear growth is falling from the normal curve in spite of adequate nutrition and normalized cardiac status. Some of these children may have growth hormone deficiency, which requires growth hormone replacement therapy.</div><div class="half_rhythm">Individuals with hypogonadotropic hypogonadism may be considered for hormone replacement therapy for induction of puberty and for general health reasons including prevention of osteoporosis.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Coloboma.</b> Tinted glasses or a dark visor can be helpful for the photophobia that often accompanies iris colobomas.</div><div class="half_rhythm">Parents, therapists, and teachers need to take into account visual field defects resulting from retinal coloboma and central visual defects resulting from optic nerve involvement and macular coloboma. For example, visual stimuli and sign language may need to be presented in child's lower visual field.</div><div class="half_rhythm">For eyes with visual potential, cycloplegic refraction and spectacle correction may be necessary, since substantive refractive errors of mildly or even moderately micro-ophthalmic eyes have been observed.</div><div class="half_rhythm">Retinal detachment, a potential complication of retinal coloboma, can result in total blindness; therefore, any change in vision status should be treated as a medical emergency.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hearing loss.</b> Hearing loss should be assumed until proven otherwise. Hearing aids and hearing habilitation (which may include sign language in addition to the auditory and speech training) should be started as soon as hearing loss is documented. Many children benefit from bone conduction aids or (especially at school) an FM system. Headbands can be used to help keep the hearing aids in place if the ear cartilage is floppy or if the tape that secures the aid to the scalp is ineffective.</div><div class="half_rhythm">PE tube placement for chronic serous otitis is common and often needs to continue until adolescence.</div><div class="half_rhythm">Cochlear implants have been successful in providing sound awareness and even speech recognition in the presence of cochlear abnormalities. <a class="bk_pop" href="#charge.REF.bauer.2002.1013">Bauer et al [2002]</a> reported successful completion of cochlear implantation and measurable benefit in five individuals with CHARGE syndrome. Of note, variations in the temporal bone anatomy can lead to technical challenges and risk to the facial nerve during implantation. In some individuals, an aberrant course of the facial nerve may be a contraindication for cochlear implant [<a class="bk_pop" href="#charge.REF.bauer.2002.1013">Bauer et al 2002</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Communication.</b> Establishing an appropriate system of communication is more difficult in the presence of both hearing loss and vision loss than in the presence of hearing loss alone. Depending on the degrees of hearing and vision loss, communication may start with touch cues, followed by object cues and proceeding to auditory/oral and/or sign language. Communication training initiated by age three years is critical to the eventual development of symbolic communication [<a class="bk_pop" href="#charge.REF.thelin.2005.282">Thelin &#x00026; Fussner 2005</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Deaf-blind service referral.</b> Children with CHARGE syndrome who have combined vision and hearing loss can be considered "deafblind," an important designation used for qualifying for educational resources in many states. Of note, "deafblind" does not imply total hearing loss or total vision loss: most children with CHARGE syndrome have some residual vision and/or hearing but are still classified as "deafblind."</div><div class="half_rhythm">Referral to deafblind education services (e.g., the Deafblind Project within the state of residence) should be made as early as possible after birth so that the parents and project personnel can begin to plan together. A growing body of evidence indicates that normal language development can occur if hearing habilitation is started prior to age six months for hearing-impaired children, whether or not they are visually impaired. Assistance of the Deafblind team to provide consultation to the early childhood education team is highly recommended since many educators and speech therapists have little or no experience with dual sensory loss.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Psychological/school evaluations</b> should be performed by a team that includes specialists in deafblindness when dual sensory loss is present. If a deafblind specialist is not available when a psychologist does an evaluation, a vision educator can show the tester where to place materials and whether the lighting and contrast of the printed materials is adequate. A hearing educator can help place the child for optimal hearing and/or do sign language interpretation.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Dental</b> procedures, when necessary, may be performed under general anesthesia.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Low muscle tone and poor balance</b> predispose children to rapid exhaustion. Many children need adjustments to the classroom or therapy setting to allow for better truncal support. Frequent rest breaks may be needed. Many children can work for longer periods if allowed to do so in a supine position [<a class="bk_pop" href="#charge.REF.williams.2005.5">Williams &#x00026; Hartshorne 2005</a>].</div><div class="half_rhythm">Unpublished data suggest that hippotherapy (horseback riding) can be a helpful adjunct to physical therapy to prevent scoliosis as it requires frequent shifts in truncal muscular control &#x02014; as do karate and other programs that promote good balance. Myofacial release can improve posture and flexibility.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Sleep cycles</b> are frequently disturbed even in those without significant visual impairments. Occasionally, sleep studies show obstructive apnea. If the cause is unknown, melatonin has been helpful for some children while others with severe visual impairment may need other medications to regulate sleep.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Chronic constipation</b> usually does not respond to simple measures such as increased fluid intake. GI consultation is often indicated.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Obsessive-compulsive disorder.</b> Behavioral therapy combined with stress reduction is sometimes helpful alone, but treatment with medications can be a useful adjunct.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Pervasive developmental disorder.</b> While the behaviors may mimic autism, there are differences [<a class="bk_pop" href="#charge.REF.hartshorne.2005a.257">Hartshorne et al 2005a</a>]. Sensory processing issues are likely implicated. Management by behavior therapy, stress reduction, and sometimes medication is indicated.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Attention-deficit hyperactivity disorder.</b> In many instances, establishing an appropriate method of communication and providing adequate stimulation for exploration in a safe environment are more helpful than medication.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Increased pain threshold</b> may predispose children to behaviors that are incorrectly interpreted by others as aggressive. Understanding this is critical to devising appropriate interventional strategies.</div></li></ul></div><div id="charge.Prevention_of_Secondary_Complicat"><h3>Prevention of Secondary Complications</h3><p><b>Facial palsy.</b> Because the facial nerves are often ectopic, an MRI to determine the location of the facial nerves is appropriate before craniofacial surgery or cochlear implantation is considered.</p><p><b>Anesthesia.</b> The airway problems associated with anesthesia in individuals with CHARGE syndrome can be attributed to choanal atresia, cleft lip and palate, and other upper-airway problems observed in approximately half of individuals with CHARGE syndrome. The soft cartilage and resultant floppy trachea add to potential anesthesia risk. Neurogenic incoordination of swallow and closure of the epiglottis may complicate the postoperative course, especially with repeated general anesthetics. If possible, procedures should be combined to reduce the overall use of anesthesia.</p></div><div id="charge.Surveillance"><h3>Surveillance</h3><p>Regular ophthalmologic evaluations are appropriate to follow changes in acuity and risks for retinal detachment and/or cataract. Monitoring nonverbal infants and children who are unable to report subjective loss of vision can permit timely detection of retinal detachment and appropriate surgical repair where necessary.</p><p>Frequent retesting of hearing by a pediatric audiologist may be necessary to determine the exact type and extent of hearing loss and to assess the success of hearing habilitation.</p><p>Frequent clinical and radiologic dental evaluations should be performed.</p><p><a class="bk_pop" href="#charge.REF.wheeler.2000.228">Wheeler et al [2000]</a> recommended that LH and FSH be obtained between age two and three months, or by age 13-14 years if puberty has not occurred. If there is reason to suspect hypogonadotropic hypogonadism, a gonadotropin-releasing hormone (GnRH) stimulation test may be helpful.</p></div><div id="charge.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#charge.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="charge.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="charge.Other"><h3>Other</h3><p>Prophylaxis for retinal detachment is not appropriate.</p></div></div><div id="charge.Genetic_Counseling"><h2 id="_charge_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="charge.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>CHARGE syndrome typically occurs in a single individual in a family, although rare <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner have been described [<a class="bk_pop" href="#charge.REF.mitchell.1985.271">Mitchell et al 1985</a>, <a class="bk_pop" href="#charge.REF.lalani.2006.303">Lalani et al 2006</a>, <a class="bk_pop" href="#charge.REF.delahaye.2007.112">Delahaye et al 2007</a>, <a class="bk_pop" href="#charge.REF.jongmans.2008.43">Jongmans et al 2008</a>, <a class="bk_pop" href="#charge.REF.vuorela.2008.249">Vuorela et al 2008</a>].</p></div><div id="charge.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with CHARGE syndrome do not have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. In rare instances, one parent may have mild features, including more than one major characteristic, in addition to minor criteria, such as a cardiovascular malformation [<a class="bk_pop" href="#charge.REF.bergman.2011.334">Bergman et al 2011</a>].</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with CHARGE syndrome usually has the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If a parent has any features of CHARGE syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is appropriate if a <i>CHD7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p>Note: Although almost all individuals diagnosed with CHARGE syndrome are the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in the family, the family history may appear to be negative because of failure to recognize the mild features of the disorder in family members.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <i>CHD7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>If neither parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the empiric risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is approximately 1%-2%, attributable to <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>Because CHARGE syndrome caused by a <i>CHD7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> typically occurs as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is small. However, several sib pairs born to unaffected parents have been reported [<a class="bk_pop" href="#charge.REF.jongmans.2006.306">Jongmans et al 2006</a>, <a class="bk_pop" href="#charge.REF.lalani.2006.303">Lalani et al 2006</a>] with likely <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, confirmed in a report by <a class="bk_pop" href="#charge.REF.pauli.2009.473">Pauli et al [2009]</a>.</div></li><li class="half_rhythm"><div>The presence of two major characteristics along with multiple <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies in a sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> should prompt complete evaluation for CHARGE syndrome. Molecular genetic testing of the sib is appropriate if a <i>CHD7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the proband.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with CHARGE syndrome do not reproduce.</div></li><li class="half_rhythm"><div>Each child of a mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with CHARGE syndrome has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The severity of CHARGE syndrome in a parent does not predict the severity of CHARGE syndrome in the offspring. Variable expression has been observed in the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents; if a parent has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CHD7</i>, his or her family members may be at risk.</p></div><div id="charge.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="charge.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>CHD7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for CHARGE syndrome are possible.</p><p><b>Ultrasound examination.</b> Some of the clinical findings in CHARGE syndrome, including polyhydramnios, heart defects, cleft lip/palate, CNS anomalies, and kidney and gastrointestinal anomalies, may be apparent on targeted level II ultrasound examination in the second trimester. <a class="bk_pop" href="#charge.REF.sanlaville.2006.211">Sanlaville et al [2006]</a> proposed performing focused fetal ultrasound and/or brain MRI for detection of external ear anomalies, choanal atresia, semicircular canal agenesis, and arrhinencephaly for a higher prenatal detection rate of CHARGE syndrome. If CHARGE syndrome is suspected, 4D ultrasound of the ears may be helpful.</p></div></div><div id="charge.Resources"><h2 id="_charge_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Association CHARGE Enfant Soleil</b></div><div>France</div><div><a href="http://www.associationcharge.fr/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.associationcharge.fr</a></div></li><li class="half_rhythm"><div><b>CHARGE Family Support Group</b></div><div>London </div><div>United Kingdom</div><div><b>Phone:</b> 020 8265 3604</div><div><b>Email:</b> si_howard@hotmail.com</div><div><a href="http://www.chargesyndrome.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.chargesyndrome.org.uk</a></div></li><li class="half_rhythm"><div><b>CHARGE Information Pack</b></div><div>Sense</div><div><a href="https://www.sense.org.uk/get-support/information-and-advice/conditions/charge-syndrome/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHARGE syndrome</a></div></li><li class="half_rhythm"><div><b>CHARGE Syndrome Association of Australasia</b></div><div>Australia</div><div><b>Phone:</b> 61 480 121 345</div><div><b>Email:</b> admin@chargesyndrome.org.au</div><div><a href="https://www.chargesyndrome.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.chargesyndrome.org.au</a></div></li><li class="half_rhythm"><div><b>CHARGE Syndrome e.V.</b></div><div>Germany</div><div><b>Phone:</b> 0049 &#x02013; (0)9104 &#x02013; 826 345</div><div><b>Email:</b> info@charge-syndrom.de</div><div><a href="http://www.charge-syndrom.de/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.charge-syndrom.de</a></div></li><li class="half_rhythm"><div><b>CHARGE Syndrome Foundation</b></div><div>141 Middle Neck Road</div><div>Sands Point NY 11050</div><div><b>Phone:</b> 800-442-7604 (toll-free); 516-684-4720</div><div><b>Fax:</b> 516-883-9060</div><div><b>Email:</b> info@chargesyndrome.org</div><div><a href="http://www.chargesyndrome.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.chargesyndrome.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=CHARGE%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHARGE syndrome</a></div></li><li class="half_rhythm"><div><b>Perkins School for the Blind</b></div><div><a href="https://www.perkinselearning.org/finder?search_api_views_fulltext=charge+syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">e-learning videos on CHARGE</a></div></li><li class="half_rhythm"><div><b>Face Equality International</b></div><div>United Kingdom</div><div><b>Email:</b> info@faceequalityinternational.org</div><div><a href="https://faceequalityinternational.org/thealliance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faceequalityinternational.org</a></div></li><li class="half_rhythm"><div><b>National Consortium on Deaf-Blindness (NCDB)</b></div><div><i>Bibliography and links to state deafblind project resources</i></div><div>345 North Monmouth Avenue</div><div>Monmouth OR 97361</div><div><b>Phone:</b> 800-438-9376 (toll-free); 800-854-7013 (TTY)</div><div><b>Fax:</b> 503-838-8150</div><div><b>Email:</b> info@nationaldb.org</div><div><a href="http://nationaldb.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nationaldb.org</a></div></li></ul></div><div id="charge.Molecular_Genetics"><h2 id="_charge_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="charge.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>CHARGE Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1117/table/charge.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__charge.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_charge.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_charge.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_charge.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_charge.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_charge.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_charge.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55636" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHD7</i></a></td><td headers="hd_b_charge.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55636" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q12<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_charge.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9P2D1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Chromodomain-helicase-DNA-binding protein 7</a></td><td headers="hd_b_charge.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHD7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHD7</a></td><td headers="hd_b_charge.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHD7[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHD7</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="charge.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="charge.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for CHARGE Syndrome (<a href="/omim/214800,608892" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1117/table/charge.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__charge.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/214800" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">214800</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHARGE SYNDROME</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608892" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608892</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 7; CHD7</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>CHD7</i> is 188 kb in size and consists of 37 coding exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1117/#charge.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and frameshift, and are distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Missense variants are also reported, although relatively infrequently [<a class="bk_pop" href="#charge.REF.aramaki.2006.410">Aramaki et al 2006</a>, <a class="bk_pop" href="#charge.REF.jongmans.2006.306">Jongmans et al 2006</a>, <a class="bk_pop" href="#charge.REF.lalani.2006.303">Lalani et al 2006</a>, <a class="bk_pop" href="#charge.REF.wincent.2008.31">Wincent et al 2008</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>CHD7</i> encodes a 2997-residue protein. It belongs to a superfamily of proteins called chromodomain helicase DNA binding protein, with two N-terminal chromodomains, a SNF2-like ATPase/helicase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and a DNA-binding domain. Chromatin remodeling is one of the mechanisms by which gene expression is regulated developmentally. CHD7 is orthologous to <i>Drosophila</i> kismet, which has been shown to facilitate an early step in transcriptional elongation by Pol II [<a class="bk_pop" href="#charge.REF.srinivasan.2008.e1000217">Srinivasan et al 2008</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> In the majority of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of CHD7 is likely the underlying basis of CHARGE syndrome.</p></div><div id="charge.References"><h2 id="_charge_References_">References</h2><div id="charge.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="charge.REF.abadie.2000.569">Abadie V, Wiener-Vacher S, Morisseau-Durand MP, Poree C, Amiel J, Amanou L, Peigne C, Lyonnet S, Manac'h Y. Vestibular anomalies in CHARGE syndrome: investigations on and consequences for postural development. <span><span class="ref-journal">Eur J Pediatr. </span>2000;<span class="ref-vol">159</span>:569–74.</span> [<a href="/pubmed/10968232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10968232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.amiel.2001.124">Amiel J, Attiee-Bitach T, Marianowski R, Cormier-Daire V, Abadie V, Bonnet D, Gonzales M, Chemouny S, Brunelle F, Munnich A, Manach Y, Lyonnet S. Temporal bone anomaly proposed as a major criteria for diagnosis of CHARGE syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">99</span>:124–7.</span> [<a href="/pubmed/11241470" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11241470</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.aramaki.2006.410">Aramaki M, Udaka T, Kosaki R, Makita Y, Okamoto N, Yoshihashi H, Oki H, Nanao K, Moriyama N, Oku S, Hasegawa T, Takahashi T, Fukushima Y, Kawame H, Kosaki K. Phenotypic spectrum of CHARGE syndrome with CHD7 mutations. <span><span class="ref-journal">J Pediatr. </span>2006;<span class="ref-vol">148</span>:410–4.</span> [<a href="/pubmed/16615981" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16615981</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.arrington.2005.326">Arrington CB, Cowley BC, Nightingale DR, Zhou H, Brothman AR, Viskochil DH. Interstitial deletion 8q11.2-q13 with congenital anomalies of CHARGE association. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">133A</span>:326–30.</span> [<a href="/pubmed/15672384" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15672384</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.bauer.2002.1013">Bauer PW, Wippold FJ 2nd, Goldin J, Lusk RP. Cochlear implantation in children with CHARGE association. <span><span class="ref-journal">Arch Otolaryngol Head Neck Surg. </span>2002;<span class="ref-vol">128</span>:1013–7.</span> [<a href="/pubmed/12220204" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12220204</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.bergman.2008.417">Bergman JE, de Wijs I, Jongmans MC, Admiraal RJ, Hoefsloot LH, van Ravenswaaij-Arts CM. Exon copy number alterations of the CHD7 gene are not a major cause of CHARGE and CHARGE-like syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2008;<span class="ref-vol">51</span>:417–25.</span> [<a href="/pubmed/18472328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18472328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.bergman.2011.334">Bergman JE, Janssen N, Hoefsloot LH, Jongmans MC, Hofstra RM, van Ravenswaaij-Arts CM. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:334–42.</span> [<a href="/pubmed/21378379" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21378379</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.bernstein.2005.232">Bernstein V, Denno LS. Repetitive behaviors in CHARGE syndrome: differential diagnosis and treatment options. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">133A</span>:232–9.</span> [<a href="/pubmed/15688425" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15688425</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.blake.1998.159">Blake KD, Davenport SL, Hall BD, Hefner MA, Pagon RA, Williams MS, Lin AE, Graham JM Jr. CHARGE association: an update and review for the primary pediatrician. <span><span class="ref-journal">Clin Pediatr (Phila). </span>1998;<span class="ref-vol">37</span>:159–73.</span> [<a href="/pubmed/9545604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9545604</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.blake.1990.217">Blake KD, Russell-Eggitt IM, Morgan DW, Ratcliffe JM, Wyse RK. Who's in CHARGE? Multidisciplinary management of patients with CHARGE association. <span><span class="ref-journal">Arch Dis Child. </span>1990;<span class="ref-vol">65</span>:217–23.</span> [<a href="/pmc/articles/PMC1792224/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1792224</span></a>] [<a href="/pubmed/2317068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2317068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.brock.2003.111">Brock KE, Mathiason MA, Rooney BL, Williams MS. Quantitative analysis of limb anomalies in CHARGE syndrome: correlation with diagnosis and characteristic CHARGE anomalies. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">123A</span>:111–21.</span> [<a href="/pubmed/14626219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14626219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.brown.2005.268">Brown D. CHARGE syndrome "behaviors": challenges or adaptations? <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">133A</span>:268–72.</span> [<a href="/pubmed/15666302" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15666302</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.chalouhi.2005.e81">Chalouhi C, Faulcon P, Bihan CL, Hertz-Pannier L, Bonfils P, Abadie V. Olfactory evaluation in children: application to the CHARGE syndrome. <span><span class="ref-journal">Pediatrics. </span>2005;<span class="ref-vol">116</span>:e81–8.</span> [<a href="/pubmed/15958661" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15958661</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.davenport.1986a.298">Davenport SL, Hefner MA, Mitchell JA. The spectrum of clinical features in CHARGE syndrome. <span><span class="ref-journal">Clin Genet. </span>1986a;<span class="ref-vol">29</span>:298–310.</span> [<a href="/pubmed/2424647" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2424647</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.davenport.1986b.137">Davenport SL, Hefner MA, Thelin JW. CHARGE syndrome. Part I. External ear anomalies. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>1986b;<span class="ref-vol">12</span>:137–43.</span> [<a href="/pubmed/3570680" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3570680</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.delahaye.2007.112">Delahaye A, Sznajer Y, Lyonnet S, Elmaleh-Berg&#x000e8;s M, Delpierre I, Audollent S, Wiener-Vacher S, Mansbach AL, Amiel J, Baumann C, Bremond-Gignac D, Atti&#x000e9;-Bitach T, Verloes A, Sanlaville D. Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability. <span><span class="ref-journal">Clin Genet. </span>2007;<span class="ref-vol">72</span>:112–21.</span> [<a href="/pubmed/17661815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17661815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.dhooge.1998.935">Dhooge I, Lemmerling M, Lagache M, Standaert L, Govaert P, Mortier G. Otological manifestations of CHARGE association. <span><span class="ref-journal">Ann Otol Rhinol Laryngol. </span>1998;<span class="ref-vol">107</span>:935–41.</span> [<a href="/pubmed/9823842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9823842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.dobbelsteyn.2005.89">Dobbelsteyn C, Marche DM, Blake K, Rashid M. Early oral sensory experiences and feeding development in children with CHARGE syndrome: a report of five cases. <span><span class="ref-journal">Dysphagia. </span>2005;<span class="ref-vol">20</span>:89–100.</span> [<a href="/pubmed/16172816" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16172816</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.doyle.2005.340">Doyle C, Blake K. Scoliosis in CHARGE: a prospective survey and two case reports. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">133A</span>:340–3.</span> [<a href="/pubmed/15688383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15688383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.edwards.2002.119">Edwards BM, Kileny PR, Van Riper LA. CHARGE syndrome: a window of opportunity for audiologic intervention. <span><span class="ref-journal">Pediatrics. </span>2002;<span class="ref-vol">110</span>:119–26.</span> [<a href="/pubmed/12093956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12093956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.gao.2007.957">Gao X, Gordon D, Zhang D, Browne R, Helms C, Gillum J, Weber S, Devroy S, Swaney S, Dobbs M, Morcuende J, Sheffield V, Lovett M, Bowcock A, Herring J, Wise C. CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">80</span>:957–65.</span> [<a href="/pmc/articles/PMC1852746/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1852746</span></a>] [<a href="/pubmed/17436250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17436250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.hannibal.2011.1511">Hannibal MC, Buckingham KJ, Ng SB, Ming JE, Beck AE, McMillin MJ, Gildersleeve HI, Bigham AW, Tabor HK, Mefford HC, Cook J, Yoshiura K, Matsumoto T, Matsumoto N, Miyake N, Tonoki H, Naritomi K, Kaname T, Nagai T, Ohashi H, Kurosawa K, Hou JW, Ohta T, Liang D, Sudo A, Morris CA, Banka S, Black GC, Clayton-Smith J, Nickerson DA, Zackai EH, Shaikh TH, Donnai D, Niikawa N, Shendure J, Bamshad MJ. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:1511–6.</span> [<a href="/pmc/articles/PMC3121928/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3121928</span></a>] [<a href="/pubmed/21671394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21671394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.hartshorne.2004.41">Hartshorne TS, Cypher AD. Challenging behavior in CHARGE syndrome. <span><span class="ref-journal">Mental Health Aspects Dev Dis. </span>2004;<span class="ref-vol">7</span>:41–52.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.hartshorne.2005a.257">Hartshorne TS, Grialou TL, Parker KR. Autistic-like behavior in CHARGE syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2005a;<span class="ref-vol">133A</span>:257–61.</span> [<a href="/pubmed/15637726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15637726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.hartshorne.2005b.228">Hartshorne TS, Hefner MA, Davenport SL. Behavior in CHARGE syndrome: introduction to the special topic. <span><span class="ref-journal">Am J Med Genet A. </span>2005b;<span class="ref-vol">133A</span>:228–31.</span> [<a href="/pubmed/15637707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15637707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.hurst.1991.54">Hurst JA, Meinecke P, Baraitser M. Balanced t(6;8)(6p8p;6q8q) and the CHARGE association. <span><span class="ref-journal">J Med Genet. </span>1991;<span class="ref-vol">28</span>:54–5.</span> [<a href="/pmc/articles/PMC1016750/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016750</span></a>] [<a href="/pubmed/1999835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1999835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.issekutz.2005.309">Issekutz KA, Graham JM Jr, Prasad C, Smith IM, Blake KD. An epidemiological analysis of CHARGE syndrome: preliminary results from a Canadian study. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">133A</span>:309–17.</span> [<a href="/pubmed/15637722" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15637722</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.johnson.2006.280">Johnson D, Morrison N, Grant L, Turner T, Fantes J, Connor JM, Murday V. Confirmation of CHD7 as a cause of CHARGE association identified by mapping a balanced chromosome translocation in affected monozygotic twins. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:280–4.</span> [<a href="/pmc/articles/PMC2563251/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2563251</span></a>] [<a href="/pubmed/16118347" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16118347</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.jongmans.2006.306">Jongmans MC, Admiraal RJ, van der Donk KP, Vissers LE, Baas AF, Kapusta L, van Hagen JM, Donnai D, de Ravel TJ, Veltman JA, Geurts van Kessel A, De Vries BB, Brunner HG, Hoefsloot LH, van Ravenswaaij CM. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:306–14.</span> [<a href="/pmc/articles/PMC2563221/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2563221</span></a>] [<a href="/pubmed/16155193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16155193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.jongmans.2008.43">Jongmans MC, Hoefsloot LH, van der Donk KP, Admiraal RJ, Magee A, van de Laar I, Hendriks Y, Verheij JB, Walpole I, Brunner HG, van Ravenswaaij CM. Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:43–50.</span> [<a href="/pubmed/18074359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18074359</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.lalani.2006.303">Lalani SR, Safiullah AM, Fernbach SD, Harutyunyan KG, Thaller C, Peterson LE, McPherson JD, Gibbs RA, White LD, Hefner M, Davenport SL, Graham JM, Bacino CA, Glass NL, Towbin JA, Craigen WJ, Neish SR, Lin AE, Belmont JW. Spectrum of CHD7 Mutations in 110 Individuals with CHARGE Syndrome and Genotype-Phenotype Correlation. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">78</span>:303–14.</span> [<a href="/pmc/articles/PMC1380237/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1380237</span></a>] [<a href="/pubmed/16400610" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16400610</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.lammer.1985.837">Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW Jr, Lott IT, Richard JM, Sun SC. Retinoic acid embryopathy. <span><span class="ref-journal">N Engl J Med. </span>1985;<span class="ref-vol">313</span>:837–41.</span> [<a href="/pubmed/3162101" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3162101</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.lemmerling.1998.462">Lemmerling M, Dhooge I, Mollet P, Mortier G, Van Cauwenberge P, Kunnen M. CT of the temporal bone in the CHARGE association. <span><span class="ref-journal">Neuroradiology. </span>1998;<span class="ref-vol">40</span>:462–5.</span> [<a href="/pubmed/9730349" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9730349</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.li.2011.715">Li Y, B&#x000f6;gershausen N, Alanay Y, Simsek Kiper PO, Plume N, Keupp K, Pohl E, Pawlik B, Rachwalski M, Milz E, Thoenes M, Albrecht B, Prott EC, Lehmk&#x000fc;hler M, Demuth S, Utine GE, Boduroglu K, Frankenbusch K, Borck G, Gillessen-Kaesbach G, Yigit G, Wieczorek D, Wollnik B. A mutation screen in patients with Kabuki syndrome. <span><span class="ref-journal">Hum Genet. </span>2011;<span class="ref-vol">130</span>:715–24.</span> [<a href="/pubmed/21607748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21607748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.micale.2011.38">Micale L, Augello B, Fusco C, Selicorni A, Loviglio MN, Silengo MC, Reymond A, Gumiero B, Zucchetti F, D'Addetta EV, Belligni E, Calcagn&#x000ec; A, Digilio MC, Dallapiccola B, Faravelli F, Forzano F, Accadia M, Bonfante A, Clementi M, Daolio C, Douzgou S, Ferrari P, Fischetto R, Garavelli L, Lapi E, Mattina T, Melis D, Patricelli MG, Priolo M, Prontera P, Renieri A, Mencarelli MA, Scarano G, Monica MD, Toschi B, Turolla L, Vancini A, Zatterale A, Gabrielli O, Zelante L, Merla G. Mutation spectrum of MLL2 in a cohort of kabuki syndrome patients. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2011;<span class="ref-vol">6</span>:38.</span> [<a href="/pmc/articles/PMC3141365/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3141365</span></a>] [<a href="/pubmed/21658225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21658225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.ming.2003.249">Ming JE, Russell KL, Bason L, McDonald-McGinn DM, Zackai EH. Coloboma and other ophthalmologic anomalies in Kabuki syndrome: distinction from charge association. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">123A</span>:249–52.</span> [<a href="/pubmed/14608645" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14608645</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.mitchell.1985.271">Mitchell JA, Giangiacomo J, Hefner MA, Thelin JW, Pickens JM. Dominant CHARGE association. <span><span class="ref-journal">Ophthalmic Paediatr Genet. </span>1985;<span class="ref-vol">6</span>:271–6.</span> [<a href="/pubmed/3934623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3934623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.morimoto.2006.1663">Morimoto AK, Wiggins RH, Hudgins PA, Hedlund GL, Hamilton B, Mukherji SK, Telian SA, Harnsberger HR. Absent semicircular canals in CHARGE syndrome: radiologic spectrum of findings. <span><span class="ref-journal">Am J Neuroradiol. </span>2006;<span class="ref-vol">27</span>:1663–71.</span> [<a href="/pubmed/16971610" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16971610</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.pauli.2009.473">Pauli S, Pieper L, H&#x000e4;berle J, Grzmil P, Burfeind P, Steckel M, Lenz U, Michelmann HW. Proven germline mosaicism in a father of two children with CHARGE syndrome. <span><span class="ref-journal">Clin Genet. </span>2009;<span class="ref-vol">75</span>:473–9.</span> [<a href="/pubmed/19475719" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19475719</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.paulussen.2011.e2018">Paulussen AD, Stegmann AP, Blok MJ, Tserpelis D, Posma-Velter C, Detisch Y, Smeets EE, Wagemans A, Schrander JJ, van den Boogaard MJ, van der Smagt J, van Haeringen A, Stolte-Dijkstra I, Kerstjens-Frederikse WS, Mancini GM, Wessels MW, Hennekam RC, Vreeburg M, Geraedts J, de Ravel T, Fryns JP, Smeets HJ, Devriendt K, Schrander-Stumpel CT. MLL2 mutation spectrum in 45 patients with Kabuki syndrome. <span><span class="ref-journal">Hum Mutat. </span>2011;<span class="ref-vol">32</span>:E2018–25.</span> [<a href="/pubmed/21280141" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21280141</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.pinto.2005.5621">Pinto G, Abadie V, Mesnage R, Blustajn J, Cabrol S, Amiel J, Hertz-Pannier L, Bertrand AM, Lyonnet S, Rappaport R, Netchine I. CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2005;<span class="ref-vol">90</span>:5621–6.</span> [<a href="/pubmed/16030162" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16030162</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.ragan.1999.622">Ragan DC, Casale AJ, Rink RC, Cain MP, Weaver DD. Genitourinary anomalies in the CHARGE association. <span><span class="ref-journal">J Urol. </span>1999;<span class="ref-vol">161</span>:622–5.</span> [<a href="/pubmed/9915472" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9915472</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.raqbi.2003.483">Raqbi F, Le Bihan C, Morisseau-Durand MP, Dureau P, Lyonnet S, Abadie V. Early prognostic factors for intellectual outcome in CHARGE syndrome. <span><span class="ref-journal">Dev Med Child Neurol. </span>2003;<span class="ref-vol">45</span>:483–8.</span> [<a href="/pubmed/12828403" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12828403</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.roger.1999.33">Roger G, Morisseau-Durand MP, Van Den Abbeele T, Nicollas R, Triglia JM, Narcy P, Abadie V, Manac'h Y, Garabedian EN. The CHARGE association: the role of tracheotomy. <span><span class="ref-journal">Arch Otolaryngol Head Neck Surg. </span>1999;<span class="ref-vol">125</span>:33–8.</span> [<a href="/pubmed/9932584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9932584</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.salemhartshorne.2005.262">Salem-Hartshorne N, Jacob S. Adaptive behavior in children with CHARGE syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">133A</span>:262–7.</span> [<a href="/pubmed/15641025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15641025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.sanlaville.2006.211">Sanlaville D, Etchevers HC, Gonzales M, Martinovic J, Clement-Ziza M, Delezoide AL, Aubry MC, Pelet A, Chemouny S, Cruaud C, Audollent S, Esculpavit C, Goudefroye G, Ozilou C, Fredouille C, Joye N, Morichon-Delvallez N, Dumez Y, Weissenbach J, Munnich A, Amiel J, Encha-Razavi F, Lyonnet S, Vekemans M, Attie-Bitach T. Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:211–7.</span> [<a href="/pmc/articles/PMC2563257/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2563257</span></a>] [<a href="/pubmed/16169932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16169932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.smith.2005.248">Smith IM, Nichols SL, Issekutz K, Blake K. Behavioral profiles and symptoms of autism in CHARGE syndrome: preliminary Canadian epidemiological data. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">133A</span>:248–56.</span> [<a href="/pubmed/15688419" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15688419</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.srinivasan.2008.e1000217">Srinivasan S, Dorighi KM, Tamkun JW. Drosophila Kismet regulates histone H3 lysine 27 methylation and early elongation by RNA polymerase II. <span><span class="ref-journal">PLoS Genet. </span>2008;<span class="ref-vol">4</span>:e1000217.</span> [<a href="/pmc/articles/PMC2563034/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2563034</span></a>] [<a href="/pubmed/18846226" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18846226</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.str_mland.2005.331">Str&#x000f6;mland K, Sjogreen L, Johansson M, Ekman Joelsson BM, Miller M, Danielsson S, Billstedt E, Gillberg C, Jacobsson C, Norinder JA, Granstrom G. CHARGE association in Sweden: malformations and functional deficits. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">133A</span>:331–9.</span> [<a href="/pubmed/15633180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15633180</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.tellier.2000.85">Tellier AL, Amiel J, Delezoide AL, Audollent S, Auge J, Esnault D, Encha-Razavi F, Munnich A, Lyonnet S, Vekemans M, Attie-Bitach T. Expression of the PAX2 gene in human embryos and exclusion in the CHARGE syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">93</span>:85–8.</span> [<a href="/pubmed/10869107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10869107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.tellier.1998.402">Tellier AL, Cormier-Daire V, Abadie V, Amiel J, Sigaudy S, Bonnet D, de Lonlay-Debeney P, Morrisseau-Durand MP, Hubert P, Michel JL, Jan D, Dollfus H, Baumann C, Labrune P, Lacombe D, Philip N, LeMerrer M, Briard ML, Munnich A, Lyonnet S. CHARGE syndrome: report of 47 cases and review. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">76</span>:402–9.</span> [<a href="/pubmed/9556299" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9556299</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.thelin.2005.282">Thelin JW, Fussner JC. Factors related to the development of communication in CHARGE syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">133A</span>:282–90.</span> [<a href="/pubmed/15669098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15669098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.thelin.1986.145">Thelin JW, Mitchell JA, Hefner MA, Davenport SL. CHARGE syndrome. Part II. Hearing loss. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>1986;<span class="ref-vol">12</span>:145–63.</span> [<a href="/pubmed/3570681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3570681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.verloes.2005.306">Verloes A. Updated diagnostic criteria for CHARGE syndrome: a proposal. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">133A</span>:306–8.</span> [<a href="/pubmed/15666308" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15666308</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.vissers.2004.955">Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, Janssen IM, van der Vliet WA, Huys EH, de Jong PJ, Hamel BC, Schoenmakers EF, Brunner HG, Veltman JA, van Kessel AG. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:955–7.</span> [<a href="/pubmed/15300250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15300250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.vuorela.2007.690">Vuorela P, Ala-Mello S, Saloranta C, Penttinen M, P&#x000f6;yh&#x000f6;nen M, Huoponen K, Borozdin W, Bausch B, Botzenhart EM, Wilhelm C, K&#x000e4;&#x000e4;ri&#x000e4;inen H, Kohlhase J. Molecular analysis of the CHD7 gene in CHARGE syndrome: identification of 22 novel mutations and evidence for a low contribution of large CHD7 deletions. <span><span class="ref-journal">Genet Med. </span>2007;<span class="ref-vol">9</span>:690–4.</span> [<a href="/pubmed/18073582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18073582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.vuorela.2008.249">Vuorela PE, Penttinen MT, Hietala MH, Laine JO, Huoponen KA, K&#x000e4;&#x000e4;ri&#x000e4;inen HA. A familial CHARGE syndrome with a CHD7 nonsense mutation and new clinical features. <span><span class="ref-journal">Clin Dysmorphol. </span>2008;<span class="ref-vol">17</span>:249–53.</span> [<a href="/pubmed/18978652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18978652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.wheeler.2000.228">Wheeler PG, Quigley CA, Sadeghi-Nejad A, Weaver DD. Hypogonadism and CHARGE association. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">94</span>:228–31.</span> [<a href="/pubmed/10995509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10995509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.white.2005.1205">White DR, Giambra BK, Hopkin RJ, Daines CL, Rutter MJ. Aspiration in children with CHARGE syndrome. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2005;<span class="ref-vol">69</span>:1205–9.</span> [<a href="/pubmed/15890414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15890414</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.wienervacher.1999.342">Wiener-Vacher SR, Amanou L, Denise P, Narcy P, Manach Y. Vestibular function in children with the CHARGE association. <span><span class="ref-journal">Arch Otolaryngol Head Neck Surg. </span>1999;<span class="ref-vol">125</span>:342–7.</span> [<a href="/pubmed/10190809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10190809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.williams.2005.5">Williams GL, Hartshorne TS. Understanding balance problems in children with CHARGE syndrome. <span><span class="ref-journal">Deaf-Blind Perspectives. </span>2005;<span class="ref-vol">12</span>:5–7.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.wincent.2008.31">Wincent J, Holmberg E, Str&#x000f6;mland K, Soller M, Mirzaei L, Djureinovic T, Robinson KL, Anderlid BM, Schoumans J. CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome. <span><span class="ref-journal">Clin Genet. </span>2008;<span class="ref-vol">74</span>:31–8.</span> [<a href="/pubmed/18445044" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18445044</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.writzl.2007.338">Writzl K, Cale CM, Pierce CM, Wilson LC, Hennekam RC. Immunological abnormalities in CHARGE syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2007;<span class="ref-vol">50</span>:338–45.</span> [<a href="/pubmed/17684005" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17684005</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.zentner.2010.674">Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:674–86.</span> [<a href="/pmc/articles/PMC2918278/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2918278</span></a>] [<a href="/pubmed/20186815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20186815</span></a>]</div></li></ul></div><div id="charge.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="charge.REF65">American Journal of Medical Genetics. Articles on CHARGE syndrome from the 6th International Charge Conference. Available <a href="https://www.chargesyndrome.org/for-families/behavior/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. Accessed 4-27-18.</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.hefner.2002">Hefner M, Davenport SLH, eds. CHARGE syndrome: a management manual for parents. Version 2.1. Columbia, MO: CHARGE Syndrome Foundation, Inc. Available <a href="https://www.chargesyndrome.org/for-families/resources/management-manual-for-parents/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2002. Accessed 4-27-18.</div></li><li class="half_rhythm"><div class="bk_ref" id="charge.REF.moss.1993">Moss K. Looking at self-stimulation in the pursuit of leisure or I'm okay, you have a mannerism. SeeHear Vol 5, no 3. TSBVI Deafblind Outreach. Available <a href="http://www.tsbvi.edu/seehear/archive/mannerism.html" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 1993. Accessed 4-27-18.</div></li></ul></div></div><div id="charge.Chapter_Notes"><h2 id="_charge_Chapter_Notes_">Chapter Notes</h2><div id="charge.Acknowledgments"><h3>Acknowledgments</h3><p>Thanks to David Weaver for assistance in procuring articles.</p></div><div id="charge.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>2 February 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 September 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 June 2007 (cd) Revision: mutation scanning added</div></li><li class="half_rhythm"><div>2 October 2006 (me) Review posted live</div></li><li class="half_rhythm"><div>14 April 2005 (jwb) Original submission</div></li></ul></div></div><div style="display:none"><div style="display:none" id="figchargeF1"><img alt="Image charge-Image001" src-large="/books/NBK1117/bin/charge-Image001.jpg" /></div><div style="display:none" id="figchargeF2"><img alt="Image charge-Image002" src-large="/books/NBK1117/bin/charge-Image002.jpg" /></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1117</span><span class="label">PMID: <a href="/pubmed/20301296" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301296</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cebpa-aml/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/chchd10-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1117&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1117/?report=reader">PubReader</a></li><li><a href="/books/NBK1117/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1117" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1117" style="display:none" title="Cite this Page"><div class="bk_tt">Lalani SR, Hefner MA, Belmont JW, et al. CHARGE Syndrome. 2006 Oct 2 [Updated 2012 Feb 2]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1117/pdf/Bookshelf_NBK1117.pdf">PDF version of this page</a> (691K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#charge.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#charge.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#charge.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#charge.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#charge.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#charge.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#charge.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#charge.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#charge.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#charge.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#charge.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55636[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHD7</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9723[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SEMA3E</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1471018" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1471018" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1471018" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1471018" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16959034" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CHARGE syndrome.</a><span class="source">[Orphanet J Rare Dis. 2006]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CHARGE syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Blake KD, Prasad C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2006 Sep 7; 1:34. Epub 2006 Sep 7.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31146700" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Feeding difficulty is the dominant feature in 12 Chinese newborns with CHD7 pathogenic variants.</a><span class="source">[BMC Med Genet. 2019]</span><div class="brieflinkpop offscreen_noflow">Feeding difficulty is the dominant feature in 12 Chinese newborns with CHD7 pathogenic variants.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chen X, Yan K, Gao Y, Wang H, Chen G, Wu B, Qin Q, Yang L, Zhou W. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Med Genet. 2019 May 30; 20(1):93. Epub 2019 May 30.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19403480" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features.</a><span class="source">[Pediatrics. 2009]</span><div class="brieflinkpop offscreen_noflow">CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jyonouchi S, McDonald-McGinn DM, Bale S, Zackai EH, Sullivan KE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatrics. 2009 May; 123(5):e871-7. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301509" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Balasubramanian R, Crowley WF Jr. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16400610" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation.</a><span class="source">[Am J Hum Genet. 2006]</span><div class="brieflinkpop offscreen_noflow">Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lalani SR, Safiullah AM, Fernbach SD, Harutyunyan KG, Thaller C, Peterson LE, McPherson JD, Gibbs RA, White LD, Hefner M, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2006 Feb; 78(2):303-14. Epub 2005 Dec 29.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301296" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301296" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04177375f66d18aa7101bd">CHARGE Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">CHARGE Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:14:11-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CB221E040C4D10000000004B901B9&amp;ncbi_session=CE8CB221E0417721_1209SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1117%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1117&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1117/&amp;ncbi_pagename=CHARGE Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CB221E0417721_1209SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>